Our Mission
Committed to significantly moving patient care forward by supporting development of commercially viable therapeutics and diagnostics. Providing all the resources necessary in-house to identify major unmet medical needs and drive impactful solutions for patients.
Venture studio focused on building companies from the ground up around innovative technologies.
Our Latest News
- Partnership enables Hibiscus BioTechnology Studio Companies access to Innoforce's advanced therapies drug development capabilities - HANGZHOU, China and ROCKVILLE, Md., March 16, 2022 /PRNewswire/ -- Innoforce, a global development…
February 03, 2022 07:05 AM Eastern Standard Time ROCKVILLE, Md.--(BUSINESS WIRE)--Regio Biosciences (Regio),a Hibiscus BioVentures company, announced today it has entered into an exclusive license agreement with AstraZeneca to further…
- Partnership aims to drive innovation and clinical development of novel therapeutics for cancer treatment - ROCKVILLE, Md.--(BUSINESS WIRE)--Hibiscus BioVentures, a firm committed to building patient-focused companies around transformative technologies,…
